Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients
- PMID: 20346026
- DOI: 10.1111/j.1365-2133.2010.09777.x
Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients
Abstract
Background: Hair loss is an unwelcome event at any age, but it can be particularly distressing for adolescents and their families. While androgenetic alopecia (AGA) is the most common form of hair loss in adults, little is known about its prevalence, clinical features and response to treatments in the paediatric population.
Objectives: To better characterize the causes of alopecia in a paediatric population.
Methods: We performed a retrospective chart review to identify all patients with hair loss seen in an academic paediatric dermatology practice at New York University over a 12-year period to better characterize the causes of alopecia in this population. We review the clinical and histological features, natural progression and associated laboratory abnormalities of AGA in 57 paediatric patients.
Results: AGA was identified as the most frequent cause of hair loss in adolescents and the second most common diagnosis overall. The male to female ratio was 2 : 1 and the average age at initial presentation with AGA was 14.8 years. Adolescent girls had diffuse thinning or thinning at the crown, and boys frequently presented with female pattern hair loss. When biopsies were performed, perifollicular inflammation was a common finding. A family history of AGA was reported in 83% of patients. Laboratory evaluation for androgens revealed polycystic ovarian syndrome in three girls and late-onset congenital adrenal hyperplasia in one boy.
Conclusions: AGA is the most common form of hair loss in adolescents, and can be the presenting sign of an underlying endocrine disorder. An accurate and timely diagnosis is essential for appropriate medical and psychosocial intervention when warranted.
Similar articles
-
Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.Arch Dermatol. 2003 Sep;139(9):1219-21. doi: 10.1001/archderm.139.9.1219-b. Arch Dermatol. 2003. PMID: 12975174 No abstract available.
-
Male pattern baldness.South Med J. 2000 Jul;93(7):657-62. South Med J. 2000. PMID: 10923949 Review.
-
Androgenetic alopecia and current methods of treatment.Acta Dermatovenerol Alp Pannonica Adriat. 2005 Mar;14(1):5-8. Acta Dermatovenerol Alp Pannonica Adriat. 2005. PMID: 15818439 Review.
-
Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.Arch Dermatol. 1995 Dec;131(12):1373-5. Arch Dermatol. 1995. PMID: 7492124 No abstract available.
-
Androgenetic alopecia in men: the scale of the problem and prospects for treatment.Int J Clin Pract. 1999 Jan-Feb;53(1):50-3. Int J Clin Pract. 1999. PMID: 10344067 Review.
Cited by
-
Case series evaluating the efficacy and safety of platelet-rich plasma for androgenetic alopecia in pediatric patients.JAAD Case Rep. 2023 May 9;37:8-12. doi: 10.1016/j.jdcr.2023.04.027. eCollection 2023 Jul. JAAD Case Rep. 2023. PMID: 37332360 Free PMC article. No abstract available.
-
A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents.Front Med (Lausanne). 2017 Jul 24;4:112. doi: 10.3389/fmed.2017.00112. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28791288 Free PMC article. Review.
-
Female pattern hair loss: clinico-laboratory findings and trichoscopy depending on disease severity.Int J Trichology. 2012 Jan;4(1):23-8. doi: 10.4103/0974-7753.96082. Int J Trichology. 2012. PMID: 22628986 Free PMC article.
-
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.Steroids. 2012 Mar 10;77(4):342-6. doi: 10.1016/j.steroids.2011.12.009. Epub 2011 Dec 13. Steroids. 2012. PMID: 22186144 Free PMC article. Review.
-
The comparison of metabolic syndrome parameters, trichoscopic and trichoscan characteristics in androgenetic alopecia (AGA) and early-onset androgenetic alopecia (early-onset AGA).Arch Dermatol Res. 2024 Aug 29;316(8):581. doi: 10.1007/s00403-024-03297-2. Arch Dermatol Res. 2024. PMID: 39207572
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous